Moderna Inc (NASDAQ:MRNA) shares, rose in value on Friday, November 01, with the stock price up by 0.30% to the previous day’s close as strong demand from buyers drove the stock to $54.52.
Actively observing the price movement in the recent trading, the stock is buoying the session at $54.36, falling within a range of $53.9 and $55.14. The value of beta (5-year monthly) is 1.661. Referring to stock’s 52-week performance, its high was $170.47, and the low was $52.26. On the whole, MRNA has fluctuated by -10.72% over the past month.
With the market capitalization of Moderna Inc currently standing at about $20.96 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2024-Nov-07.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 3.22B, with a low estimate of 842.2M and a high estimate of 1.47B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 1.24B.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that MRNA’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of MRNA currently trading nearly -1.99% and -15.74% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 33.09, while the 7-day volatility ratio is showing 3.88% which for the 30-day chart, stands at 3.58%. Furthermore, Moderna Inc (MRNA)’s beta value is 1.69, and its average true range (ATR) is 2.26.
A comparison of Moderna Inc (MRNA) with its peers suggests the former has fared considerably weaker in the market. MRNA showed an intraday change of 0.30% in today’s session so far, and over the past year, it shrunk by -28.45%%.
Data on historical trading for Moderna Inc (NASDAQ:MRNA) indicates that the trading volumes over the past 10 days have averaged 4.56 and over the past 3 months, they’ve averaged 5.15 million. According to company’s latest data on outstanding shares, there are 382.00 million shares outstanding.
Nearly 10.83% of Moderna Inc’s shares belong to company insiders and institutional investors own 67.96% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 33.26 million shares as on 2024-10-15, resulting in a short ratio of 6.47. According to the data, the short interest in Moderna Inc (MRNA) stood at 1138.00 of shares outstanding as of 2024-10-15; the number of short shares registered in 2024-09-13 reached 27.61 million. The stock has fallen by -45.18% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MRNA stock heading into the next quarter.
